S&P 500   5,065.72 (-0.08%)
DOW   38,900.38 (-0.43%)
QQQ   437.00 (+0.10%)
AAPL   180.97 (-0.10%)
MSFT   405.45 (-0.51%)
META   484.23 (+0.52%)
GOOGL   138.16 (+0.43%)
AMZN   174.12 (-0.35%)
TSLA   202.15 (+1.38%)
NVDA   787.21 (-0.47%)
NIO   5.78 (+2.30%)
AMD   177.10 (+0.62%)
BABA   77.41 (+1.18%)
T   16.66 (+0.36%)
F   12.05 (+0.84%)
MU   91.05 (+1.78%)
CGC   3.54 (+2.02%)
GE   153.71 (-0.68%)
DIS   108.42 (+0.69%)
AMC   4.67 (+4.94%)
PFE   26.99 (-0.70%)
PYPL   59.66 (+0.56%)
XOM   104.35 (+0.10%)
S&P 500   5,065.72 (-0.08%)
DOW   38,900.38 (-0.43%)
QQQ   437.00 (+0.10%)
AAPL   180.97 (-0.10%)
MSFT   405.45 (-0.51%)
META   484.23 (+0.52%)
GOOGL   138.16 (+0.43%)
AMZN   174.12 (-0.35%)
TSLA   202.15 (+1.38%)
NVDA   787.21 (-0.47%)
NIO   5.78 (+2.30%)
AMD   177.10 (+0.62%)
BABA   77.41 (+1.18%)
T   16.66 (+0.36%)
F   12.05 (+0.84%)
MU   91.05 (+1.78%)
CGC   3.54 (+2.02%)
GE   153.71 (-0.68%)
DIS   108.42 (+0.69%)
AMC   4.67 (+4.94%)
PFE   26.99 (-0.70%)
PYPL   59.66 (+0.56%)
XOM   104.35 (+0.10%)
S&P 500   5,065.72 (-0.08%)
DOW   38,900.38 (-0.43%)
QQQ   437.00 (+0.10%)
AAPL   180.97 (-0.10%)
MSFT   405.45 (-0.51%)
META   484.23 (+0.52%)
GOOGL   138.16 (+0.43%)
AMZN   174.12 (-0.35%)
TSLA   202.15 (+1.38%)
NVDA   787.21 (-0.47%)
NIO   5.78 (+2.30%)
AMD   177.10 (+0.62%)
BABA   77.41 (+1.18%)
T   16.66 (+0.36%)
F   12.05 (+0.84%)
MU   91.05 (+1.78%)
CGC   3.54 (+2.02%)
GE   153.71 (-0.68%)
DIS   108.42 (+0.69%)
AMC   4.67 (+4.94%)
PFE   26.99 (-0.70%)
PYPL   59.66 (+0.56%)
XOM   104.35 (+0.10%)
S&P 500   5,065.72 (-0.08%)
DOW   38,900.38 (-0.43%)
QQQ   437.00 (+0.10%)
AAPL   180.97 (-0.10%)
MSFT   405.45 (-0.51%)
META   484.23 (+0.52%)
GOOGL   138.16 (+0.43%)
AMZN   174.12 (-0.35%)
TSLA   202.15 (+1.38%)
NVDA   787.21 (-0.47%)
NIO   5.78 (+2.30%)
AMD   177.10 (+0.62%)
BABA   77.41 (+1.18%)
T   16.66 (+0.36%)
F   12.05 (+0.84%)
MU   91.05 (+1.78%)
CGC   3.54 (+2.02%)
GE   153.71 (-0.68%)
DIS   108.42 (+0.69%)
AMC   4.67 (+4.94%)
PFE   26.99 (-0.70%)
PYPL   59.66 (+0.56%)
XOM   104.35 (+0.10%)
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

$7.77
+0.05 (+0.65%)
(As of 11:27 AM ET)
Today's Range
$7.60
$7.95
50-Day Range
$7.72
$11.21
52-Week Range
$6.60
$15.87
Volume
255,666 shs
Average Volume
575,758 shs
Market Capitalization
$455.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.14

Health Catalyst MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.71 Rating Score
Upside/​Downside
72.5% Upside
$13.14 Price Target
Short Interest
Healthy
2.56% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
0.29mentions of Health Catalyst in the last 14 days
Based on 30 Articles This Week
Insider Trading
Selling Shares
$50,692 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.84) to ($0.76) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.79 out of 5 stars

Medical Sector

46th out of 943 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

3rd out of 57 stocks


HCAT stock logo

About Health Catalyst Stock (NASDAQ:HCAT)

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

HCAT Stock Price History

HCAT Stock News Headlines

KeyCorp Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $10.00
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Analyst Scoreboard: 5 Ratings For Health Catalyst
Q4 2023 Health Catalyst Inc Earnings Call
Health Catalyst Inc (HCAT)
See More Headlines
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2021
Today
2/27/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Current Symbol
NASDAQ:HCAT
Fax
N/A
Employees
1,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.14
High Stock Price Target
$18.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+72.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
14 Analysts

Profitability

Net Income
$-118,150,000.00
Pretax Margin
-39.80%

Debt

Sales & Book Value

Annual Sales
$295.94 million
Book Value
$6.38 per share

Miscellaneous

Free Float
56,982,000
Market Cap
$446.25 million
Optionable
Optionable
Beta
1.35
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report














HCAT Stock Analysis - Frequently Asked Questions

Should I buy or sell Health Catalyst stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HCAT shares.
View HCAT analyst ratings
or view top-rated stocks.

What is Health Catalyst's stock price target for 2024?

14 Wall Street analysts have issued 12 month price targets for Health Catalyst's shares. Their HCAT share price targets range from $8.00 to $18.00. On average, they anticipate the company's stock price to reach $13.14 in the next year. This suggests a possible upside of 72.5% from the stock's current price.
View analysts price targets for HCAT
or view top-rated stocks among Wall Street analysts.

How have HCAT shares performed in 2024?

Health Catalyst's stock was trading at $9.26 at the beginning of 2024. Since then, HCAT shares have decreased by 17.7% and is now trading at $7.62.
View the best growth stocks for 2024 here
.

Are investors shorting Health Catalyst?

Health Catalyst saw a decline in short interest in the month of January. As of January 31st, there was short interest totaling 1,500,000 shares, a decline of 15.7% from the January 15th total of 1,780,000 shares. Based on an average daily volume of 547,500 shares, the short-interest ratio is presently 2.7 days.
View Health Catalyst's Short Interest
.

When is Health Catalyst's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our HCAT earnings forecast
.

How were Health Catalyst's earnings last quarter?

Health Catalyst, Inc. (NASDAQ:HCAT) released its quarterly earnings data on Tuesday, November, 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.04. The company earned $61.74 million during the quarter, compared to the consensus estimate of $60.95 million. Health Catalyst had a negative trailing twelve-month return on equity of 12.19% and a negative net margin of 39.92%. During the same quarter in the prior year, the firm posted ($0.44) earnings per share.

What guidance has Health Catalyst issued on next quarter's earnings?

Health Catalyst issued an update on its first quarter 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $72.5 million-$76.5 million, compared to the consensus revenue estimate of $79.0 million.

What is Dan Burton's approval rating as Health Catalyst's CEO?

501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL).

When did Health Catalyst IPO?

(HCAT) raised $129 million in an initial public offering on Thursday, July 25th 2019. The company issued 6,000,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Who are Health Catalyst's major shareholders?

Health Catalyst's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.57%), Point72 Asset Management L.P. (7.22%), Impax Asset Management Group plc (3.05%), Dimensional Fund Advisors LP (2.69%), Primecap Management Co. CA (2.47%) and Granahan Investment Management LLC (2.14%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn and Paul Horstmeier.
View institutional ownership trends
.

How do I buy shares of Health Catalyst?

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HCAT) was last updated on 2/27/2024 by MarketBeat.com Staff